Dibasic calcium phosphate anhydrous – Excipient for premium tablet compression
1. General introduction to Dibasic calcium phosphate anhydrous
Dibasic calcium phosphate anhydrous (DCPA) is one of the most widely used excipients in modern tablet manufacturing. With the chemical formula CaHPO₄, it appears as a high-purity white powder that is odorless, tasteless, and completely free of crystalline water, ensuring excellent stability throughout production and storage.
The key advantage of DCPA over conventional excipients lies in its direct compression capability, eliminating the need for complex granulation processes. This allows manufacturers to streamline production, reduce operational costs, and significantly improve manufacturing efficiency, especially in large-scale facilities. DCPA is considered a strategic excipient solution for pharmaceutical companies targeting premium product segments, stringent quality standards, and global market competitiveness.
2. Chemical composition of Dibasic calcium phosphate anhydrous
Chemical formula - CaHPO₄: A stable inorganic calcium phosphate compound widely used as an excipient and mineral source in formulations.
Form - Anhydrous (no water of crystallization): Provides superior stability and minimizes sensitivity to environmental humidity compared to dihydrate forms.
Mineral content - High bioavailable calcium and phosphorus: Suitable for both pharmaceutical and nutraceutical applications requiring high-quality mineral supplementation.
Key chemical characteristics:
Insoluble in water: Ensures formulation stability and maintains tablet integrity during storage.
Soluble in dilute acids (HCl, HNO₃): Supports bioavailability and effective release in physiological conditions.
Chemically inert: Highly compatible with APIs, minimizing the risk of unwanted interactions.
3. Advantages of Dibasic calcium phosphate anhydrous
Dibasic calcium phosphate anhydrous is recognized as a strategic excipient for large-scale manufacturing due to the following advantages:
Higher stability than dihydrate forms: Reduces formulation variability and enhances product consistency.
Non-hygroscopic: Ideal for moisture-sensitive APIs and formulations.
Excellent direct compression capability: Eliminates granulation steps and reduces production costs.
Improves tablet hardness: Enhances mechanical strength and reduces breakage.
Good flowability: Optimizes performance in high-speed manufacturing processes.
4. Applications of Dibasic calcium phosphate anhydrous
In pharmaceuticals
Tablets: Provides bulk, improves hardness, and ensures uniformity
Direct compression tablets: Enables simplified manufacturing without granulation
Capsules: Enhances powder flow and formulation stability
Calcium supplements: Delivers a stable and bioavailable calcium source
Vitamins and minerals: Stabilizes multi-component formulations
In food applications
Dietary supplements: Provides bioavailable calcium and phosphorus
Fortified milk:Enhances nutritional value and stability
Breakfast cereals: Improves mineral content and product structure
Bakery products: Functions as a leavening and stabilizing agent
High-purity dibasic calcium phosphate anhydrous for premium tablet compression. Enhances hardness, stability, and production efficiency in advanced pharmaceutical formulations
Cupric sulphate pentahydrate is a high purity antimicrobial copper compound used for disinfection, microbial control, and advanced applications in pharmaceuticals, cosmetics, and water treatment systems
Croscarmellose sodium is a high-performance superdisintegrant enhancing rapid tablet disintegration, bioavailability, and formulation efficiency for pharmaceutical, cosmetic, and nutraceutical applications
High-purity Chlorobutanol hemihydrate for sterile pharmaceutical applications. Effective antimicrobial activity, enhanced stability, and compliance with international standards
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
